- Home
- XERS vs HCSG Comparison
XERS vs HCSG Comparison
Compare XERS & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | HCSG |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Assisted Living Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XERS | HCSG |
|---|---|---|
| Price | $10.51 | $20.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $12.86 | ★ $26.67 |
| AVG Volume (30 Days) | ★ 2.3M | 639.6K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | 52.83 |
| EPS | N/A | ★ 0.69 |
| Revenue | $49,590,000.00 | ★ $1,837,173,000.00 |
| Revenue This Year | $32.91 | $4.55 |
| Revenue Next Year | $23.75 | $7.01 |
| P/E Ratio | ★ N/A | $29.94 |
| Revenue Growth | ★ 142.67 | 7.08 |
| 52 Week Low | $5.25 | $15.36 |
| 52 Week High | $10.35 | $25.75 |
Technical Indicators
Market Signals| Indicator | XERS | HCSG |
|---|---|---|
| Relative Strength Index (RSI) | 69.93 | 37.07 |
| Support Level | $7.15 | $20.26 |
| Resistance Level | N/A | $20.67 |
| Average True Range (ATR) | 0.52 | 0.50 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 99.03 | 26.69 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About HCSG Healthcare Services Group Inc.
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.